Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Capital Expenditures: 2020-2024

Historic Capital Expenditures for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $16,000.

  • Candel Therapeutics' Capital Expenditures fell 82.97% to $47,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $457,000, marking a year-over-year decrease of 64.76%. This contributed to the annual value of $16,000 for FY2024, which is 96.50% down from last year.
  • According to the latest figures from FY2024, Candel Therapeutics' Capital Expenditures is $16,000, which was down 96.50% from $457,000 recorded in FY2023.
  • Over the past 5 years, Candel Therapeutics' Capital Expenditures peaked at $1.8 million during FY2021, and registered a low of $16,000 during FY2024.
  • Over the past 3 years, Candel Therapeutics' median Capital Expenditures value was $457,000 (recorded in 2023), while the average stood at $590,000.
  • In the last 5 years, Candel Therapeutics' Capital Expenditures climbed by 24.32% in 2021 and then slumped by 96.50% in 2024.
  • Candel Therapeutics' Capital Expenditures (Yearly) stood at $1.5 million in 2020, then climbed by 24.32% to $1.8 million in 2021, then decreased by 29.32% to $1.3 million in 2022, then crashed by 64.76% to $457,000 in 2023, then tumbled by 96.50% to $16,000 in 2024.